This year’s recipients of the Silver Gavel Awards for Media and the Arts delve into a multitude of pressing and prominent legal issues, including abortion rights, affirmative action and modern-day slavery.
Federal appeals court nominee Michael Delaney is withdrawing his nomination after controversies surfaced over a stance that he took in a legal brief and his defense of a private school.
Newly released private papers of then-Justice John Paul Stevens provide insight into U.S. Supreme Court deliberations and concerns before its decisions that decided a presidential election and affirmed the right to abortion.
Justice Samuel Alito says he personally has “a pretty good idea who is responsible” for the May 2, 2022, leak of the U.S. Supreme Court’s abortion decision, “but that’s different from the level of proof that is needed to name somebody.”
A Texas federal judge who blocked access to the abortion drug mifepristone did not disclose certain information about the millions of dollars in stock that he owns when he filled out financial disclosure forms for 2020 and 2021.
Justices Samuel Alito and Clarence Thomas dissented from the U.S. Supreme Court’s decision Friday to allow continued full access, for now, to the abortion medication mifepristone. But Alito spoke only for himself in a written dissent; Thomas did not indicate the reason for his dissent.
Justice Samuel Alito on Wednesday extended an administrative stay to give the U.S. Supreme Court more time to consider an emergency request to allow full access to the abortion drug mifepristone during a challenge to its approval.
A Texas federal judge who ruled against the government in an abortion pill case withdrew his name from a controversial law review article before his nomination to the bench.
U.S. Supreme Court Justice Samuel Alito granted an administrative stay Friday that temporarily allows access to the abortion drug mifepristone for up to 10 weeks of pregnancy, as well as access through the mail.
Updated: Anti-abortion doctors and medical associations likely sued too late to revoke the U.S. Food and Drug Administration’s 2000 approval of the abortion pill mifepristone, a federal appeals court has ruled in temporarily staying part of an April 7 decision by U.S. District Judge Matthew J. Kacsmaryk of Texas.
The ABA Journal wants to host and facilitate conversations among lawyers about their profession. We are now accepting thoughtful, non-promotional articles and commentary by unpaid contributors.
